Syntropic
Syntropic is developing HAVENTM, a non-invasive brain stimulation device that restores neuroplasticity to treat depression. By delivering precise pulsed light stimulation, HAVENTM activates microglia, the brain’s immune cells, to remodel extracellular structures that block neuroplasticity. Syntropic’s technology is based on pioneering discovery by our scientific co-founders Prof. Sandra Siegert and Dr. Alessandro Venturino at ISTA, Institute of Science and Technology Austria.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Syntropic
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- AA
Amin Alam
Research and Development Engineer · Other
EmailPhone - AV
Alessandro Venturino
Managing Director · Manufacturing & Production
EmailPhone - MC
Mark Caffrey
Founder · Other
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Syntropic
3 distinct titles indexed · top 3 shown.
- 1founder
- 1managing director
- 1research and development engineer
Sign up to unlock all 4 contacts at Syntropic
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Syntropic
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.